Description

Adamax 5mg × 10 vials

A synthetic Semax-derived neuropeptide studied for nootropic research, neuroprotection models, cognitive-function pathways, stress-response mechanisms, neuronal resilience, neurotransmitter signaling, and broader central nervous system research protocols.

Product Overview

Compound: Adamax
Strength: 5 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Notes

Adamax is commonly described in research-product literature as a modified Semax-derived peptide, often referenced as an N-acetyl Semax-based compound with an adamantyl structural modification.

It is studied in relation to neuropeptide signaling, cognitive-function models, neuroprotection pathways, stress-response research, neuronal stability, and central nervous system regulation.

Because Adamax is a less established research compound compared with Semax, available published human-context data remain limited. It should not be treated as a standard therapeutic, wellness, or performance product.

Most available evidence comes from laboratory, supplier-referenced, and limited preclinical-context research. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.